Institution
University of Paris
Education•Paris, France•
About: University of Paris is a education organization based out in Paris, France. It is known for research contribution in the topics: Population & Medicine. The organization has 102426 authors who have published 174180 publications receiving 5041753 citations. The organization is also known as: Sorbonne.
Topics: Population, Medicine, Context (language use), Transplantation, Gene
Papers published on a yearly basis
Papers
More filters
New York University1, University of Amsterdam2, Shiga University of Medical Science3, Kyungpook National University4, St George's, University of London5, Children's National Medical Center6, Leiden University7, University of Barcelona8, University of Oulu9, Vanderbilt University10, University of British Columbia11, University of Paris12, University of Rochester13, University of Pavia14, Nippon Medical School15, Johns Hopkins University16, Washington University in St. Louis17
TL;DR: Developed in partnership with the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology, and the Asia Pacific Heart Rhythm society (APHRS).
1,569 citations
TL;DR: In this paper, the authors review recent progress, from both in situ experiments and advanced simulation techniques, in understanding the charge storage mechanism in carbon- and oxide-based supercapacitors.
Abstract: Supercapacitors are electrochemical energy storage devices that operate on the simple mechanism of adsorption of ions from an electrolyte on a high-surface-area electrode. Over the past decade, the performance of supercapacitors has greatly improved, as electrode materials have been tuned at the nanoscale and electrolytes have gained an active role, enabling more efficient storage mechanisms. In porous carbon materials with subnanometre pores, the desolvation of the ions leads to surprisingly high capacitances. Oxide materials store charge by surface redox reactions, leading to the pseudocapacitive effect. Understanding the physical mechanisms underlying charge storage in these materials is important for further development of supercapacitors. Here we review recent progress, from both in situ experiments and advanced simulation techniques, in understanding the charge storage mechanism in carbon- and oxide-based supercapacitors. We also discuss the challenges that still need to be addressed for building better supercapacitors.
1,565 citations
TL;DR: In this paper, a mathematical study of the differentiable deformations of the algebras associated with phase space is presented, and deformations invariant under any Lie algebra of "distinguished observables" are studied.
1,564 citations
University of Amsterdam1, Columbia University2, Rush University Medical Center3, Cornell University4, University of Washington5, National Institutes of Health6, Leiden University7, Imperial College London8, Vanderbilt University9, SUNY Downstate Medical Center10, Ohio State University11, St. Vincent's Health System12, University of North Carolina at Chapel Hill13, National University of Malaysia14, University of Paris15, University of Malaya16, Okayama University17, Federal University of São Paulo18, University of Tsukuba19
TL;DR: The main advantages of the current revised classification is that it provides a clear and unequivocal description of the various lesions and classes of lupus nephritis, allowing a better standardization and lending a basis for further clinicopathologic studies.
1,561 citations
New York University1, National and Kapodistrian University of Athens2, University of Barcelona3, Texas Oncology4, Complutense University of Madrid5, Aix-Marseille University6, University of Toronto7, University of Oxford8, University of Queensland9, University of Colorado Denver10, Emory University11, Cross Cancer Institute12, Centre Hospitalier Universitaire de Toulouse13, Georgetown University14, University of Sydney15, University of Washington16, University of Paris17, Nagoya University18, Seoul National University19, Bristol-Myers Squibb20, The Royal Marsden NHS Foundation Trust21
TL;DR: Among patients undergoing resection of stage IIIB, IIIC, or IV melanoma, adjuvant therapy with nivolumab resulted in significantly longer recurrence‐free survival and a lower rate of grade 3 or 4 adverse events than adjuant therapy with ipilimumab.
Abstract: BackgroundNivolumab and ipilimumab are immune checkpoint inhibitors that have been approved for the treatment of advanced melanoma. In the United States, ipilimumab has also been approved as adjuvant therapy for melanoma on the basis of recurrence-free and overall survival rates that were higher than those with placebo in a phase 3 trial. We wanted to determine the efficacy of nivolumab versus ipilimumab for adjuvant therapy in patients with resected advanced melanoma. MethodsIn this randomized, double-blind, phase 3 trial, we randomly assigned 906 patients (≥15 years of age) who were undergoing complete resection of stage IIIB, IIIC, or IV melanoma to receive an intravenous infusion of either nivolumab at a dose of 3 mg per kilogram of body weight every 2 weeks (453 patients) or ipilimumab at a dose of 10 mg per kilogram every 3 weeks for four doses and then every 12 weeks (453 patients). The patients were treated for a period of up to 1 year or until disease recurrence, a report of unacceptable toxic ef...
1,549 citations
Authors
Showing all 102613 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Guido Kroemer | 236 | 1404 | 246571 |
| David H. Weinberg | 183 | 700 | 171424 |
| Paul M. Thompson | 183 | 2271 | 146736 |
| Chris Sander | 178 | 713 | 233287 |
| Sophie Henrot-Versille | 171 | 957 | 157040 |
| Richard H. Friend | 169 | 1182 | 140032 |
| George P. Chrousos | 169 | 1612 | 120752 |
| Mika Kivimäki | 166 | 1515 | 141468 |
| Martin Karplus | 163 | 831 | 138492 |
| William J. Sandborn | 162 | 1317 | 108564 |
| Darien Wood | 160 | 2174 | 136596 |
| Monique M.B. Breteler | 159 | 546 | 93762 |
| Paul Emery | 158 | 1314 | 121293 |
| Wolfgang Wagner | 156 | 2342 | 123391 |
| Joao Seixas | 153 | 1538 | 115070 |